Viral infections result in cellular stress responses, which can trigger protein translation shutoff via phosphorylation of eukaryotic initiation factor 2 alpha (eIF2a). Newcastle disease virus (NDV) causes severe disease in poultry and selectively kills human tumour cells. In this report, we determined that infection of HeLa human cervical cancer cells and DF-1 chicken fibroblast cells with NDV maintained protein at early infection times, 0-12 h post-infection (p.i.), and gradually inhibited global protein translation at late infection times, 12-24 h p.i. Mechanistic studies showed that translation inhibition at late infection times was accompanied by phosphorylation of eIF2a, a checkpoint of translation initiation. Meanwhile, the eIF2a kinase, PKR, was upregulated and activated by phosphorylation and another eIF2a kinase, PERK, was phosphorylated and cleaved into two fragments. Pharmacological inhibition experiments revealed that only PKR activity was required for eIF2a phosphorylation, suggesting that recognition of viral dsRNA by PKR was responsible for translation shutoff. High levels of phospho-eIF2a led to preferential translation of the transcription factor ATF4 and an increase in GADD34 expression. Functionally, GADD34, in conjunction with PP1, dephosphorylated eIF2a and restored protein translation, benefiting virus protein synthesis. However, PP1 was degraded at late infection times, functionally counteracting the upregulation of GADD34. Taken together, our data support that NDV-induced translation shutoff at late infection times was attributed to sustaining phosphorylation of eIF2a, which is mediated by continual activation of PKR and degradation of PP1.
Viral infections result in cellular stress responses, which can trigger protein translation shutoff via phosphorylation of eukaryotic initiation factor 2 alpha (eIF2a). Newcastle disease virus (NDV) causes severe disease in poultry and selectively kills human tumour cells. In this report, we determined that infection of HeLa human cervical cancer cells and DF-1 chicken fibroblast cells with NDV maintained protein at early infection times, 0-12 h post-infection (p.i.), and gradually inhibited global protein translation at late infection times, 12-24 h p.i. Mechanistic studies showed that translation inhibition at late infection times was accompanied by phosphorylation of eIF2a, a checkpoint of translation initiation. Meanwhile, the eIF2a kinase, PKR, was upregulated and activated by phosphorylation and another eIF2a kinase, PERK, was phosphorylated and cleaved into two fragments. Pharmacological inhibition experiments revealed that only PKR activity was required for eIF2a phosphorylation, suggesting that recognition of viral dsRNA by PKR was responsible for translation shutoff. High levels of phospho-eIF2a led to preferential translation of the transcription factor ATF4 and an increase in GADD34 expression. Functionally, GADD34, in conjunction with PP1, dephosphorylated eIF2a and restored protein translation, benefiting virus protein synthesis. However, PP1 was degraded at late infection times, functionally counteracting the upregulation of GADD34. Taken together, our data support that NDV-induced translation shutoff at late infection times was attributed to sustaining phosphorylation of eIF2a, which is mediated by continual activation of PKR and degradation of PP1.
INTRODUCTION
Newcastle disease virus (NDV) is an avian paramyxovirus that causes respiratory diseases and death in poultry. NDV has a negative-sense, ssRNA genome of at least three sizes comprising 15 186, 15 192 and 15 198 nt, respectively . During virus replication, six mRNAs are produced, encoding structural protein nucleocapsid protein (NP), phosphoprotein (P), matrix protein (M), fusion protein (F), haemagglutinin-neuraminidase (HN) and large polymerase protein (L). The mRNA encoding P protein also encodes non-structural proteins V and W through RNA editing. V protein inhibits interferon-b production through binding to MDA-5 (Childs et al., 2007) . For virus genome replication, the negative strand RNA genome is transcribed into a positive strand anti-genomic RNA, which in turn serves as a template for the synthesis of new negative strand RNA genome, and forms a dsRNA intermediate (Alexander, 2000) .
Virus life cycles depend on host machinery for viral protein production and therefore viruses must effectively seize control of host translation factors and their associated extensive regulatory network. With respect to infection, host protein translation is regulated primarily at the ratelimiting initiation step, which involves ribosome recruitment to mRNA. Prior to their recruitment to mRNAs, 40S ribosome subunits bind to translation initiation factor 1 (eIF1), eIF1A, eIF3 complexes and eIF5, along with eIF2-GTP, to assemble a 43S-pre-initiation complex loaded with charged initiator-methionine tRNAi (MettRNAi) (Jackson et al., 2010) . Eukaryotic initiation factor 2 alpha (eIF2a) plays a critical role in the onset of translation. Phosphorylation of eIF2a on Ser51 increases the affinity for the eIF2b subunit and prevents regeneration of GTP in the ternary complex eIF2-GTPMet tRNAi, thus halting the ignition of protein translation. Since eIF2b is limited, small changes in phospho-eIF2a concentration have dramatic effects on translation initiation (Hinnebusch & Lorsch, 2012) . PERK, PKR, HRI and GCN2 are four kinases responsible for eIF2a phosphorylation on residue Ser51 (Proud et al., 2005) . Among them, PERK is activated by autophosphorylation on Thr980 in response to excess accumulation of unfolded proteins in the endoplasmic reticulum (ER) lumen (Harding et al., 2002; Schröder & Kaufman, 2005) , while PKR is activated by autophosphorylation on Thr446 and Thr451 in response to viral dsRNA (Gale & Katze, 1998; Williams, 1999) . Phospho-PERK and phospho-PKR phosphorylate eIF2a and shut down protein translation (Harding et al., 1999; Williams, 1999) . Because of the central importance of eIF2a in initiation or shutoff of mRNA translation, different viruses have evolved various mechanisms to regulate phosphorylation of eIF2a (He et al., 1997; Kazemi et al., 2004; Mulvey et al., 2007; Pavio et al., 2003; Wang et al., 2009) .
Although eIF2a phosphorylation leads to translation inhibition, some specific mRNAs are preferentially translated, such as activating transcription factor 4 (ATF4). ATF4 promotes the transcription of lots of genes, including growth arrest and DNA damage-inducible protein 34 (GADD34) (Ma et al., 2002) . It is well known that GADD34 is a regulatory subunit of the protein phosphatase 1 (PP1), which promotes dephosphorylation of eIF2a, hence recovering protein translation (Novoa et al., 2001 ).
We recently showed that different NDV strains activated PKR and phosphorylated eIF2a at late infection times . The aim of the current study was to investigate the mechanisms of protein translation regulation during NDV infection. Using SUnSET, a non-radioactive method to monitor protein synthesis (Schmidt et al., 2009) , we found that infection of HeLa cells and DF-1 cells with NDV Herts/33 strain maintained protein synthesis at early infection times and suppressed protein translation at late infection times. PKR was responsible for eIF2a phosphorylation and subsequent translation shutoff. ATF4 was preferentially translated, thereby enhancing expression of GADD34. Further investigation showed that the PP1 was degraded during NDV infection. Sustained activation of PKR and degradation of PP1 resulted in accumulation of phospho-eIF2a and protein translation shutoff at late infection times.
RESULTS
Reduced translation rate and increased eIF2a phosphorylation at late times after infection with NDV To measure the protein translation rate during NDV infection, HeLa cells were either mock-infected or NDVinfected, subjected to pulse-chase puromycin labelling for 1 h and harvested at 0, 4, 8, 12, 16, 20 and 24 h postinfection (p.i.). De novo protein synthesis was assessed by Western blot analysis with the anti-puromycin mAb 12D10, which detected the newly synthesized protein labelled with puromycin. The results showed that mockinfected cells maintained a high level of protein translation rate at all time points. In NDV-infected cells, a robust protein translation rate was sustained at 0-12 h p.i., and a gradual inhibition of protein translation was observed at 12-24 h p.i., with increased expression of NDV NP protein as an indication of infection (Fig. 1a) . Quantification of the puromycin-labelled bands by densitometry measurement showed a 0.88-0.07-fold decrease in the translation rate at 12-24 h p.i. in NDV-infected cells, compared with mock-infected cells (Fig. 1a) . A bar graph showing three biological replicates combined is shown in the lower panel of Fig. 1(a) . To demonstrate that the NDV-induced translation inhibition was not restricted to HeLa cells, chicken DF-1 cells were either mock-infected or NDVinfected, and subjected to puromycin labelling. Western blot analysis showed that the protein translation rate was also sustained at 0-12 h p.i., and decreased by 0.35-0.07-fold at 12-24 h p.i. (Fig. 1b) . Again, increased expression of NP protein at 12-24 h p.i. was observed. A bar graph showing three biological replicates combined is shown in the lower panel of Fig. 1(b) . The above results demonstrated that NDV infection led to global translation shutoff at late infection times in cell types of different species. The robust translation of viral protein NP might be due to overwhelming viral mRNA produced at late infection times or preferential translation of viral mRNA.
The translation initiation factor eIF2a is a key regulator of translation and is functionally inhibited by phosphorylation on Ser51. To determine whether the rate change of global protein synthesis correlated with eIF2a phosphorylation, HeLa cells were either mock-infected or NDVinfected, and were harvested at 0, 4, 8, 12, 16, 20 and 24 h p.i. Cell lysates were analysed by immunoblotting with antibodies specific for phospho-eIF2a on Ser51 or total eIF2a. As shown in Fig. 1(c) , significantly elevated levels (4.6-6-fold) of phospho-eIF2a were detected in NDV-infected cells at 12-20 h p.i., compared with that in mock-infected cells. The level of phospho-eIF2a was declined at 24 h p.i., when almost all the cells were dead and detached from the culture plate. These data suggested that NDV infection led to a significant increase in phospho-eIF2a at late infection times, which resulted in an overall decrease in protein translation.
To investigate the role of eIF2a phosphorylation in NDV infection, two constructs encoding the wt eIF2a and a non-phosphorylatable eIF2a-S51A were transiently expressed in HeLa cells, followed by NDV infection and puromycin labelling. The vector PXJ40F was transfected in a parallel experiment as control. The phosphorylation site was abolished in the S51A mutant and overexpression of eIF2a-S51A was expected to facilitate translation. As shown in Fig. 1(d Mock-infected or NDV-infected cells were metabolically pulse-chase labelled with puromycin for 1 h at 3, 7, 11, 15, 19 and 23 h p.i. Cells were harvested at 4, 8, 12, 16, 20 and 24 h p.i. Cell lysates were prepared, resolved by 12 % SDS-PAGE and probed with the indicated antibodies. De novo protein synthesis was assessed by Western blot analysis using anti-puromycin antibody 12D10 (top panel). NDV NP protein was detected by NP mAb to monitor NDV replication (middle panel). Western blot analysis of b-actin and Coomassie brilliant blue G-250 staining of total cellular proteins were included to document equivalent protein loading (bottom panels). The intensities of puromycin-incorporated bands were determined by densitometry, and the protein translation rate was shown as fold change after normalization to b-actin. The signals for puromycin in mock-infected cells at each time point were treated as 1. Each experiment was done three times. Bar graphs are shown in (a) and (b), and error bars represent SD of the mean (n53). (c) Phosphorylation of eIF2a in NDV-infected cells. HeLa cells were either mock-infected or NDV-infected, and harvested at 0, 4, 8, 12, 16, 20 and 24 h p.i. Cell lysates were subjected to Western blot analysis using antibodies against phospho-eIF2a, eIF2a, NP and b-actin. The intensities of phospho-eIF2a bands were determined by densitometry, normalized to eIF2a, and eIF2a-S51A was much lower than that in cells transfected with wt eIF2a (2.3-fold) or PXJ40F (2.1-fold). Consistent with low levels of phospho-eIF2a, the global protein translation rate (presented by puromycin incorporated proteins) was increased by 3.4-fold and viral protein NP was increased by 1.5-fold in the presence of eIF2a-S51A, compared with PXJ40F-transfected cells. Unexpectedly, although the protein translation rate was enhanced by twofold in wt eIF2a overexpressing cells due to high levels of eIF2a, the synthesis of viral protein NP was reduced by 0.6-fold. The underlying mechanisms need further study. Based on the above observations, we concluded that a low level of phospho-eIF2a promoted global protein translation and viral protein synthesis, and a high level of phospho-eIF2a had an inhibitory effect on global protein translation and viral protein synthesis.
Activation of PKR and cleavage of PERK at late infection times
During RNA virus infection, eIF2a phosphorylation usually occurs as a result of activation of PKR by dsRNA, as well as activation of PERK induced by ER stress. Previous work has shown that both the NDV lentogenic strain LaSota and the velogenic strain Herts/33 triggered PKR activation and eIF2a phosphorylation in HeLa cells, and PKR was necessary for NDV-induced IFN-b transcription . To further clarify the kinases responsible for phosphorylation of eIF2a, the phosphorylation level and the expression level of PKR were assessed again in this study. Cell lysates harvested at different times p.i. were analysed by Western blotting with antibodies against phospho-PKR on Thr446 and total PKR. As shown in Fig. 2 (a), increased expression of PKR (2.4-1.9-fold) was detected at 12, 16 and 20 h p.i., compared with that in mock-infected cells. Moreover, high levels of phospho-PKR (78-132-fold) were detected at 12, 16, 20 and 24 h p.i. (Fig. 2a) , consistent with the high levels of phospho-eIF2a observed in Fig.  1 (c). To further clarify the involvement of PKR in eIF2a phosphorylation, NDV-infected HeLa cells were treated with a PKR inhibitor, 2-aminopurine (2-AP) (Hu et al., 1993) , for 2 h at 14 h p.i. PBS was added in a parallel experiment as control. Cells were harvested at 16 h p.i. and subjected to Western blot analysis. Results showed that the levels of phospho-eIF2a were decreased by 0.5-fold in the presence of 2-AP (Fig. 2b) , suggesting that PKR kinase activity is required for eIF2a phosphorylation.
We next investigated the activity of another eIF2a kinase, PERK, which is activated in response to accumulation of unfolded proteins in the ER lumen. Cell lysates harvested at different times of p.i. were analysed by Western blotting with antibodies against phospho-PERK on Thr980 and total PERK. The Western blot showed that full-length phospho-PERK on Thr980 (150 kDa) was increased at 12 h p.i., by 1.2-fold, and decreased by 0.7-0.3-fold at 16, 20 and 24 h p.i. (Fig. 2c ). Contrary to our expectations, a 70 kDa band corresponding to the C-terminal fragment of phospho-PERK (the antibody recognizes an epitope surrounding PERK residues 950-1050 with phosphate on Thr980) was detected at 12, 16, 20 and 24 h p.i. (Fig. 2c) , suggesting that phospho-PERK was cleaved during NDV infection. Consistent with the cleavage of phospho-PERK, total PERK was also cleaved at 12, 16, 20 and 24 h p.i., with a decrease in full-length PERK (150 kDa) and an increase in the 100 kDa N-terminal fragment of PERK (the antibody recognizes an epitope surrounding Leu156 of PERK) along the infection time-course (Fig. 2c) . These results demonstrated that PERK was phosphorylated and cleaved during late infection times. The cleavage of PERK, as observed here, has not been reported either in other virus infections nor other types of treatment.
To further clarify the involvement of PERK in eIF2a phosphorylation, NDV-infected HeLa cells were treated with the PERK/PKR inhibitor, GSK2606414, in increasing concentrations (0-1000 nM) for 2 h at 14 h p.i. DMSO was added in a parallel experiment as a control. A low dose of GSK2606414 inhibits PERK activity (IC 50 : 0.4 nM) and a high dose of GSK2606414 inhibits PKR activity (IC 50 : 696 nM) (Axten et al., 2012) . Cells were harvested at 16 h p.i. and subjected to Western blot analysis. The results showed that GSK2606414 did not reduce the levels of phospho-eIF2a at 0-100 nM, the dose completely inhibiting PERK activity (Fig. 2d) . When the concentration of GSK2606414 was increased to 1000 nM, the dose inhibiting PKR, the level of phospho-eIF2a was reduced by 0.9-fold. These results demonstrated that PERK did not participate in the phosphorylation of eIF2a. Based on above results, we concluded that the upregulation and activation of PKR was responsible for the high levels of phosphoeIF2a and translation shutoff at late times of NDV infection.
Upregulation of ATF4 and GADD34 at late infection times eIF2a phosphorylation preferentially enhances transcription factor ATF4 synthesis, followed by the transcription of many downstream target genes, including GADD34 (Harding et al., 2000) . Consequently, GADD34 helps PP1
shown as fold change (virus : mock). (d) Global translation recovery by exogenous expression of non-phosphorylatable eIF2a-S51A. HeLa cells were transfected with PXJ40F, PXJ40F-eIF2a and PXJ40F-eIF2a-S51A, followed by mock infection or NDV infection, and metabolically pulse-chase labelled with puromycin for 1 h at 15 h p.i. Cells lysates were prepared at 16 h p.i. and subjected to Western blot analysis using antibodies against puromycin, phospho-eIF2a, eIF2a, NP and b-actin. The intensities of puromycin, phospho-eIF2a and NP were determined by densitometry, normalized to b-actin, eIF2a or b-actin, respectively, and shown as fold change. The band signals in PXJ40F transfected cells were treated as 1. The above experiments were repeated three times.
to desphosphorylate eIF2a and recovers translation (Brush et al., 2003) . The expression ATF4 and GADD34 in NDVinfected cells were therefore examined by Western blot analysis. As shown in Fig. 3(a) , significant upregulation of ATF4 protein (1.1-5.2-fold) was detected in NDVinfected cells at 8, 12, 16 and 20 h p.i., compared with mock-infected cells. Consistent with the Western blot result, immunofluorescence staining showed that ATF4 was upregulated and translocated into the nucleus as a transcription factor (Fig. 3b) . As expected, the expression of GADD34 was dramatically induced at 12 h p.i. To investigate the role of upregulation of GADD34 in global protein translation rate and viral protein synthesis, Flag-tagged GADD34 protein was exogenously expressed in HeLa cells by transfection of the plasmid PXJ40F-GADD34, followed by infection with NDV and puromycin labelling. The vector PXJ40F was transfected in a parallel experiment as a control. Cells were harvested at 16 h p.i. and subjected to Western blot analysis. Successful expression of Flag-tagged GADD34 was confirmed by Western blotting using anti-Flag antibody (Fig. 3c) . In GADD34 exogenously expressing cells, phospho-eIF2a was reduced by 0.2-fold, global translation rate was enhanced by 8.1-fold and viral protein NP was increased by 2.2-fold, compared with PXJ40F-transfected cells (Fig. 3c) . These results demonstrated that upregulation of GADD34 promoted dephosphorylation of eIF2a and recovered translation, which was favourable to viral protein synthesis.
PP1 degradation during NDV infection at late infection times
We next investigated the expression of the GADD34 partners, the catalytic subunits PP1a and PP1c. Using an antibody that reacts with the phosphorylated form of PP1a, Western blot analysis demonstrated that phosphoPP1a on Thr320 was maintained at constant levels at 4 and 8 h p.i., and was decreased by 0.8-0.1-fold at 12, 16, 20 and 24 h p.i. in NDV-infected cells, compared with mock-infected cells (Fig. 4a) . Dephosphorylation of PP1 on Thr320 is known to lead to the enhancement of its enzymic activity (Kwon et al., 1997) . Upregulation of the regulatory subunit GADD34 could facilitate self-dephosphorylation of PP1. Unexpectedly, a significant decrease in total PP1a (0.2-0.8-fold) and PP1c (0.4-0.8-fold) was observed at 16-24 h p.i. (Fig. 4a) , suggesting that PP1 was degraded during NDV infection.
MG132 is a proteasome inhibitor that prevents ubiquitinproteasome dependent protein degradation. To investigate whether degradation of PP1 was ubiquitin-proteasome dependent, HeLa cells were either mock-or NDV-infected, then treated with 5 mM MG132, followed by puromycin labelling. The Western blot analysis in Fig. 4(b) showed that MG132 prevented the degradation of PP1a and PP1c, resulting in accumulation of PP1a and PP1c at 20 (c) Enhancement of translation rate and facilitation of NDV protein synthesis by exogenous expression of GADD34. HeLa cells were transfected with PXJ40F or PXJ40F-GADD34 for 24 h and infected with NDV. Cells were labelled with puromycin for 1 h at 15 h p.i. and harvested at 16 h p.i. Western blot analysis was carried out using antibodies against puromycin, phospho-eIF2a, eIF2a, NP and b-actin. The intensities of puromycin, phospho-eIF2a and NP were determined by densitometry, normalized to b-actin, eIF2a or b-actin, respectively, and shown as fold change (GADD34 : PXJ40F). The above experiments were repeated three times and results were reproducible.
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and 24 h p.i. Viral protein NP was decreased by 0.5-fold in MG132 treated cells, suggesting that overall infection was reduced (Fig. 4b) . The inhibition of virus replication by MG132 was also reported in hepatitis E virus and hepatitis C virus (Xu et al., 2015) . Consistent with the reduced virus infection and higher levels of PP1a and PP1c, less translation inhibition was observed in the presence of MG132 (Fig. 4b, upper panel) . Above results suggested that the low levels of PP1a and PP1c in NDV-infected cells were due to ubiquitin-proteasome dependent degradation, which might be mediated by virus specific mechanisms or intrinsic short half-life of PP1.
Accumulation of phospho-eIF2a and inhibition of protein translation by PP1/PP2A inhibitors
In order to investigate the functional consequences of the GADD34 upregulation and PP1 degradation, we next evaluated whether PP1 activity was required to control the level of phospho-eIF2a and protein translation rate during NDV infection. The serine/threonine phosphatase inhibitor, okadaic acid, a broad PP1 and PP2A inhibitor (Cohen et al., 1989) , was added into virus-infected cells at increasing concentrations (0-1250 nM) for 1 h at 10 and 14 h p.i. Cells were then subjected to puromycin labelling and harvested at 12 and 16 h p.i. Okadaic acid (1-2 nM) completely inhibited PP2A and 1 mM okadaic acid completely inhibited PP1 (Cohen et al., 1989) . As shown in Fig. 5(a) , in NDV-infected cells, a low dose of okadaic acid (10 nM) did not increase the levels of phospho-eIF2a, indicating that PP2A (IC 50 : 0.1 nM) did not participate in dephosphorylation of eIF2a. However, when 50 nM okadaic acid was used, which is higher than the IC 50 of PP1 (IC 50 : 15-20 nM), the levels of phospho-eIF2a accumulated at 16 h p.i. When the dose of okadaic acid was increased to 250 and 1250 nM, the levels of phospho-eIF2a were significantly enhanced by 130-134-fold at 12 h p.i. and by 147-187-fold at 16 h p.i. (Fig. 5a ), compared with that in mock-infected cells. These results implied that PP1 was the main phosphatase of eIF2a. Consistent with the accumulation of phospho-eIF2a, the puromycin-incorporated proteins were reduced to undetectable levels in the presence of 250-1250 nM okadaic acid (Fig. 5b) . The bar graph in Fig. 5b shows protein translation rate with quantification values of three biological replicates. The accumulation of phospho-eIF2a and subsequent translation shutoff by a high dose of okadaic acid demonstrated that although PP1 was partially degraded, it still partially functioned in dephosphorylation of eIF2a during NDV infection.
Calyculin A is another fast-acting phosphotase inhibitor and is potent against PP1 and PP2A (Ishihara et al., 1989) . To further confirm the above result, Calyculin A was added into NDV-infected cells at increasing concentrations (0-12.5 nM) 30 min prior to puromycin labelling. Cells were harvested at 12 and 16 h p.i. and subjected to Western blot analysis. As shown in Fig. 5(c) , 0-0.5 nM of Calyculin A did not promote the accumulation of phospho-eIF2a and inhibition of protein translation, suggesting PP2A (IC 50 : 0.5-1 nM) may not be involved in the dephosphorylation of eIF2a. When the concentrations of Calyculin A were increased to 2.5-12.5 nM, the levels of phosphoeIF2a were significantly increased by 123-fold at 12 h p.i. and 70-143-fold at 16 h p.i. (Fig. 5c) , suggesting that PP1 (IC 50 : 2 nM) is required for eIF2a dephosphorylation. Consistent with the accumulation of phospho-eIF2a, the puromycin-incorporated proteins were reduced to undetectable levels in the presence of 2.5-12.5 nM Calyculin A (Fig. 5d) . The bar graph in Fig. 5(d) shows protein translation rate with quantification values of three biological replicates. The effects of Calyculin A on the accumulation of phospho-eIF2a and inhibition of translation rate suggested that PP1 had an effect on the dephosphorylation of eIF2a during NDV infection.
DISCUSSION
Host cell-dependent viral protein translation is a crucial step for virus replication and assembly. In response to virus infection, host cells usually shut off protein translation by inducing cellular stress or detection of viral dsRNA as a defence mechanism. However, many viruses manipulate host protein translation mechanisms to facilitate their own replication. In light of this, we undertook the investigation of translation regulation by NDV in HeLa cells and DF-1 cells. Our goal was to acquire insight into some of the basic responses, processes and molecules involved in translation regulation by NDV in tumour cells and chicken cells. We focused our investigation on the canonical responses to virus infection, namely, the ER stress response and the PKR response, which regulate the translation machinery through the phosphorylation of eIF2a.
The phosphorylation of eIF2a is a checkpoint of protein translation initiation, and the level of phospho-eIF2a is modulated by the opposing activities of kinases and phosphatases. Our data showed that NDV infection maintained protein translation by restraining eIF2a phosphorylation (Fig. 1b) and enhancing 4E-BP1 and eIF4E phosphorylation at 0-12 h p.i. (data not shown). Robust protein translation at early infection times is essential for the virus to complete its life cycle. Over the late infection timecourse, at 12-24 h p.i., NDV infection led to phosphorylation of eIF2a on Ser51, thereby impairing translation initiation and resulting in protein synthesis shutoff. We further observed that PKR was upregulated and activated at 12-24 h p.i., and its kinase activity was required for eIF2a phosphorylation. It was believed that the IFN-b released from the NDV-infected cells induced PKR expression in neighbouring cells and PKR was activated by viral dsRNA. Meanwhile, large amounts of viral proteins accumulated in the ER activated and led to PERK phosphorylation. However, PERK was cleaved by unknown mechanisms and did not participate in eIF2a phosphorylation. High levels of phospho-eIF2a led to the preferential translation and nuclear translocation of transcription factor ATF4, inducing the transcription of PP1 regulatory subunit GADD34. By targeting phospho-eIF2a, GADD34-PP1 can antagonize any eIF2a kinases. However, PP1 was depleted at 12-24 h p.i., counteracting the upregulation of GADD34, resulting in low enzymatic activity. The activation of PKR and depletion of PP1 are the major causes of phospho-eIF2a accumulation and HeLa cells were either mock-or NDV-infected, and the NDV-infected cells were treated with increasing concentrations of okadaic acid for 1 h at 10 and 14 h p.i., followed by puromycin labelling for 1 h. Cells were harvested at 12 and 16 h p.i., and subjected to Western blot analysis using antibodies against phospho-eIF2a, eIF2a, NP and b-actin. The intensity of phospho-eIF2a was determined by densitometry, and was shown as fold change after normalization to total eIF2a. The signals for phospho-eIF2a in mock-infected cells were considered as 1. (b) Impairment of translation rate by the PP1/PP2A inhibitor okadaic acid (OA) in NDV-infected cells. Cell lysates prepared in (a) were subjected to Western blot analysis using antipuromycin antibody 12D10, to assess de novo protein synthesis (top panel). Equivalent protein loading was confirmed by Coomassie brilliant blue G-250 staining (bottom panel). The intensity of puromycin was determined by densitometry, and the protein translation rate was shown as fold change after normalization to b-actin in (a). The signals of puromycin in mockinfected cells were treated as 1. The above experiments were done three times and were reproducible. Protein translation rates are shown in a bar graph and error bars represent SD of the mean (n53). (c) Accumulation of phospho-eIF2a by PP1/PP2A inhibitor Calyculin A treatment in NDV-infected cells. HeLa cells were either mock-or NDV-infected, and the NDV-infected HeLa cells were treated with 0, 0.1, 0.5, 2.5 or 12.5 nM of Calyculin A for 30 min at 10.5 and 14.5 h p.i., followed by puromycin labelling for 1 h. Cell lysates were prepared at 12 and 16 h p.i., and were subjected to Western blot analysis, demonsitometry and quantification as described in (a). (d) The impairment of translation rate by PP1/PP2A inhibitor Calyculin A in NDV-infected cells. Cell lysates prepared in (c) were subjected to Western blot analysis, Coomassie brilliant blue G-250 staining, densitometry and quantification as described in (b). The above experiments were done three times and were reproducible. Protein translation rates are shown in a bar graph and error bars represent SD of the mean (n53).
translation shutoff at late infection times (Fig. 6) . The impairment of cellular protein synthesis plays a significant role in viral pathogenesis by promoting apoptosis and restricting the translation of mRNAs encoding inflammatory cytokines and interferon-stimulated genes.
GADD34 is upregulated as a canonical cellular stress response to enhance PP1 activity and thereby dephosphorylates eIF2a. Some viruses have been demonstrated to induce GADD34 expression to benefit their replication. One example is infectious bronchitis virus, a chicken coronavirus that induces GADD34 expression and maintains de novo protein synthesis in infected cells (Wang et al., 2009) . Moreover, some viruses encode viral proteins mimicking the function of GADD34. These viral GADD34 mimicking proteins include transmissible gastroenteritis virus nonstructural protein 7 (Cruz et al., 2011) , Herpes simplex virus 1 ICP34.5 (He et al., 1998) , African swine fever virus DPL71 protein (Zhang et al., 2010a) and porcine alpha-herpes-virus pseudorabies virus early viral protein IE180 (Van Opdenbosch et al., 2012) . GADD34 helps PP1 to dephosphorylate eIF2a and maintain protein synthesis; meanwhile, it also aids PP1 dephosphorylate RIG-I/MDA5, TAK1, TBK1 and IKKb (Gu et al., 2014; Li et al., 2008; Qu et al., 2015; Wies et al., 2013) . Therefore, GADD34-PP1 could also be considered as an integral part of the innate immunity signalling cascades by regulation of protein synthesis and IFN production.
Our pharmacological inhibition study showed that inhibition of PP1 activity promoted the accumulation of phospho-eIF2a at late infection times, suggesting that PP1 targets eIF2a for dephosphorylation. However, due to the partial degradation of PP1 during late infection times, the dephosphorylation of eIF2a by PP1 was limited.
Eventually, the robust PKR activity and relatively weak PP1 enzymic activity led to high levels of phospho-eIF2a and resulted in translation shutoff at late infection times. The degradation of PP1 during virus infection, as observed here, has not been reported in connection to other virus infections or other type of treatment. However, there are several reports that have showed the inhibition of PP1 activity by measles virus, which also belongs to Paramyxoviridae. Measles virus subverts PP1-mediated dephosphorylation and activation of RIG-I-like receptors in two ways. First, measles virus bind to DC-SIGN leading to activation of Raf-1 kinase, which induces the association of PP1 inhibitor I-1 with GADD34-PP1 holoenzymes, thereby inhibiting phosphatase activity (Mesman et al., 2014) . Second, V protein of measles virus interacts with PP1a/c and serves as a substrate for dephosphorylation by PP1, which competitively prevents PP1-mediated dephosphorylation of MDA5, and thereby, its activation (Davis et al., 2014) . Another paramyxovirus, Nipah virus, also encodes V protein that binds to PP1 and inhibits the dephosphorylation of MDA5 (Davis et al., 2014) . Therefore, antagonizing PP1 function might be a common mechanism utilized by paramyxoviruses to evade innate immune recognition. In our study, we found that pharmacological inhibition of PP1 activity promoted the phosphorylation of TAK1, IKKb and TBK1 in NDV infected cells (data not shown), demonstrating that PP1 was involved not only in translation regulation, but also in regulation of innate immune signalling pathways. The induction of GADD34 and degradation of PP1 during NDV infection represent viral-specific mechanisms that subtly regulate protein synthesis and IFN production. PP1. Identification of viral specific proteins involved in PP1 degradation will provide further insights into the mechanistic details. Furthermore, the role of GADD34-PP1 in the regulation of innate immunity pathways in NDV-infected cells needs further exploration.
In conclusion, our study provides a comprehensive picture of the translation inhibition mechanisms during NDV infection. Understanding the mechanisms of NDV interactions with the translation control pathways will help elucidate the positive and negative consequences of these pathways on NDV pathogenesis or oncolytic mechanisms.
METHODS
Cell culture and virus. The HeLa human cervical cancer cell line and the DF-1 chicken fibroblast cell line were purchased from ATCC and were maintained in Dulbecco's modified Eagle's medium with 4500 mg glucose l 21 supplemented with 10 % FBS (Hyclone), penicillin (100 units ml 21 ) and streptomycin (100 mg ml 21 ) (Invitrogen) at 37 uC in a 5 % CO 2 incubator.
The NDV velogenic strain Herts/33 was purchased from China Institute of Veterinary Drug Control (Beijing, China). The viruses were propagated in embryonated chicken eggs and titrated on DF-1 cells. Virus was used for infection at an m.o.i. of 1 throughout this study.
Reagents and antibodies. The PKR inhibitor 2-AP was purchased from Sigma-Aldrich. The PERK/PKR inhibitor GSK2606414 and proteosome inhibitor MG132 were purchased from Selleck Chemicals. The PP1/PP2A inhibitor okadaic acid and Calyculin A were purchased from Cell Signaling Technology. The RNA extraction reagent Trizol and Lipofectamine 3000 were purchased from Invitrogen Thermo Fisher Scientific.
Monoclonal NDV NP protein antibody was raised in mice using bacterially expressed His-tagged NP protein as the immunogen. Antibodies against phospho-PKR (Thr451), PKR, PERK, phosphoeIF2a (Ser51), eIF2a, phospho-PP1a (Thr320), PP1a, caspase 3, PARP, ATF4, GADD34 and b-actin were purchased from Cell Signaling Technology. Antibody against phospho-PERK was purchased from Abcam. Antibody against PP1c was purchased from Santa Cruz Technology. mAb 12D10 against puromycin was purchased from EMD Millipore. The secondary IgG conjugated with HRP, FITC or TRITC were obtained from DAKO.
Transfection of plasmid DNA. Cells were grown to 70-80 % confluence before transfection with plasmid DNA. Each transfection was carried out using Lipofectamine 3000 reagent according to the manufacturer's standard protocol. Cells were then infected with NDV at an m.o.i. of 1 at 24 h post-transfection and incubated for 15 h before puromycin labelling.
Western blot analysis. Cells were lysed with 1| SDS loading buffer in the presence of 100 mM DTT and denatured at 100 uC for 5 min. Equivalent amounts of protein were separated by SDS-PAGE, followed by transfer onto PVDF membranes (Bio-Rad) by electroblotting. Immunoblot analysis was then performed by incubating membranes with appropriate antibodies in blocking buffer for 1 h at room temperature. After washing three times with PBST, membranes were incubated with HRP-conjugated secondary antibody for 1 h and washed with PBST three times. Blots were developed with an enhanced chemiluminescence (ECL) detection system (GE Healthcare Life Sciences) and exposed to X-ray film (Fuji). Membranes were stripped by stripping buffer (10 mM b-mercaptoethanol, 2 % SDS, 62.5 mM Tris, pH 6.8) at 55 uC for 30 min before they were reprobed using another antibody.
Puromycin labelling. HeLa cells were infected with NDV and then labelled with 10 mg puromycin ml 21 for 1 h at different time points p.i. After puromycin labelling, all cells were washed three times in cold PBS and lysed in 1| SDS protein loading buffer. Equivalent amounts of protein were separated by 12 % SDS-PAGE, stained by Coomassie brilliant blue G-250 to document equivalent protein loading or subjected to Western blot analysis using anti-puromycin antibody or indicated antibodies.
Pharmacological inhibition experiment. For the PKR or PERK activity inhibition experiment, 10 mg 2-AP ml 21 or increasing concentrations (0, 0.4, 10, 100, 1000 nM) of GSK2606414 was added into NDV-infected cells for 2 h at 14 h p.i. Cells were harvested at 16 h p.i. and subjected to Western blot analysis.
For the proteasome pathway inhibition experiment, 5 mM MG132 was added onto cells immediately after infection and incubated for 19 and 23 h, followed by puromycin labelling.
For the PP1/PP2A activity inhibition experiment, NDV-infected cells were treated with increasing concentrations of okadaic acid (0, 10, 50, 250, 1250 nM) for 1 h at 10 and 14 h p.i., followed by puromycin labelling, or treated with increasing concentrations of Calyculin A (0, 0.1, 0.5, 2.5, 12.5 nM) for 30 min at 10.5 h and 14.5 h, followed by puromycin labelling.
Immunofluorescence assay. Hela cells were seeded on four-well chamber slides and infected with NDV. Cells were fixed with 4 % paraformaldehyde for 10 min at 16 h p.i., washed three times with PBS, permeabilized with 0.2 % Triton X-100 for 10 min and washed three times with PBS. Monoclonal ATF4 antibody (raised in rabbit) was used to detect ATF4 protein. Monoclonal NP antibody (raised in mouse) was used to monitor virus infection. Cells were incubated with ATF4 antibody (1 : 200) and NP antibody (1 : 200) diluted in PBS (5 % BSA) for 2 h, washed with PBS twice and then incubated with secondary antibody conjugating with FITC or TRITC (DAKO) for 2 h (1 : 200 diluted in PBS, 5 % BSA) and washed with PBS three times. Cells were then incubated with 0.1 mg ml 21 DAPI diluted in PBS for 10 min and rinsed three times with PBS. Finally, the specimen was mounted with glass coverslips using fluorescent mounting medium (DAKO) containing 15 mM NaN 3 . Images were collected with a META 510 confocal laser-scanning microscope (Zeiss).
Plasmid construction. eIF2a and GADD34 were PCR amplified from cellular cDNAs and cloned into the vector PXJ40F (with a Flag tag) under control of a cytomegalovirus promoter, generating PXJ40F-eIF2a and PXJ40F-GADD34, respectively. The eIF2a-S51A mutant was constructed by site-directed mutagenesis (Stratagene).
Densitometry. The intensities of corresponding bands were quantified using ImageJ program (NIH).
